SCHEMBL355892

SCHEMBL355892

NN1C=CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27512900 0.97
SCHEMBL28416504 0.71
SCHEMBL444155 0.67
SCHEMBL3176188 0.67
SCHEMBL28247868 0.67
SCHEMBL28242392 0.67
Ammonia Solution, Strong SCHEMBL29574382 0.65
Ethane SCHEMBL27619247 0.65
SCHEMBL10799347 0.64
SCHEMBL11062500 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103936690-B Aminodihydrothiazine derivatives 盐野义制药株式会社 2016-06-08 CN disclosed
EP-2597087-B1 Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors SHIONOGI & CO (JP) 2016-03-30 EP disclosed
US-20150210680-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO (JP) 2015-07-30 US disclosed
US-9029358-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2015-05-12 US disclosed
EP-2612854-B1 Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors SHIONOGI & CO (JP) 2015-04-29 EP disclosed
US-8895548-B2 Pharmaceutical composition for treating alzheimer's disease SHIONOGI & CO., LTD. (JP) 2014-11-25 US disclosed
US-8815851-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2014-08-26 US disclosed
CN-103936690-A Aminodihydrothiazine derivatives SHIONOGI & CO 2014-07-23 CN disclosed
EP-1942105-B1 AMINODIHYDROTHIAZINE DERIVATIVE SHIONOGI & CO (JP) 2014-04-16 EP disclosed
CN-101346357-B Aminodihydrothiazine derivatives SHIONOGI & CO 2014-04-02 CN disclosed
CN-101346357-A Aminodihydrothiazine derivatives SHIONOGI & CO (JP) 2009-01-14 CN disclosed
EP-1942105-A1 AMINODIHYDROTHIAZINE DERIVATIVE Shionogi Co., Ltd. (JP) 2008-07-09 EP disclosed
CN-1738817-A Novel antagonist derivatives of vitronectin receptors, process for their preparation, their use as medicaments and pharmaceutical compositions containing them PROSKELIA SAS (FR) 2006-02-22 CN disclosed
EP-1282621-B1 VITRONECTIN RECEPTOR ANTAGONISTS AVENTIS PHARMA SA (FR) 2005-09-07 EP disclosed
US-6838453-B2 Antagonist derivatives of the vitronectin receptor AVENTIS PHARMA S.A. (FR) 2005-01-04 US disclosed
US-20040225111-A1 ANTAGONIST DERIVATIVES OF THE VITRONECTIN RECEPTOR AVENTIS PHARMA S.A. (FR) 2004-11-11 US disclosed
EP-1282621-A1 VITRONECTIN RECEPTOR ANTAGONISTS Aventis Pharma S.A. (FR) 2003-02-12 EP disclosed
WO-2001085729-A1 NOVEL VITRONECTIN RECEPTOR ANTAGONISTS AVENTIS PHARMA S.A. (FR) 2001-11-15 WO disclosed
US-4322421-A 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydro-pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1982-03-30 US disclosed
US-4261995-A DISORDERS OF CENTRAL NERVOUS SYSTEM AND CARDIOVASCULAR SYSTEM; HYPOTENSIVE SYNTEX (U.S.A.) INC. (US) 1981-04-14 US disclosed